Paratek Pharmaceuticals, Inc. Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Paratek Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Paratek Pharmaceuticals, Inc. for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 7,500 | 0 | 13,500 | 6 K to 13.5 K (+125.00 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Grant | A | 0.00 | 7,500 | 0 | 10,500 | 3 K to 10.5 K (+250.00 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Peterson Kristine | Director | Grant | A | 0.00 | 7,500 | 0 | 13,500 | 6 K to 13.5 K (+125.00 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Franson Timothy R | Director | Grant | A | 0.00 | 7,500 | 0 | 13,500 | 6 K to 13.5 K (+125.00 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 7,500 | 0 | 16,830 | 9.3 K to 16.8 K (+80.39 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 29,250 | 0 | 80,617 | 51.4 K to 80.6 K (+56.94 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 29,250 | 0 | 68,820 | 39.6 K to 68.8 K (+73.92 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 58,500 | 0 | 203,370 | 144.9 K to 203.4 K (+40.38 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Grant | A | 0.00 | 27,000 | 0 | 62,458 | 35.5 K to 62.5 K (+76.15 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Grant | A | 0.00 | 63,000 | 0 | 186,680 | 123.7 K to 186.7 K (+50.94 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Radie Robert S | Director | Sell | S | 14.22 | 3,000 | 42,660 | 3,000 | 6 K to 3 K (-50.00 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Haskel William M. | Sr. VP, Sec. & Gene ... | Sell | S | 14.22 | 1,081 | 15,372 | 35,458 | 36.5 K to 35.5 K (-2.96 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 14.22 | 3,040 | 43,229 | 144,870 | 147.9 K to 144.9 K (-2.06 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Chairman and CEO | Sell | S | 14.22 | 4,000 | 56,880 | 123,680 | 127.7 K to 123.7 K (-3.13 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 13.77 | 11,000 | 151,470 | 51,367 | 62.4 K to 51.4 K (-17.64 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 14.22 | 3,333 | 47,395 | 62,367 | 65.7 K to 62.4 K (-5.07 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 14.22 | 16,291 | 231,658 | 39,570 | 55.9 K to 39.6 K (-29.16 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Sell | S | 14.22 | 2,100 | 29,862 | 9,330 | 11.4 K to 9.3 K (-18.37 %) |